TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.40$ +3.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ALXO
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– -0.5% -52.9% -74.8% +570.6% +144.4% +4.3% -19.0%
– +10.4% +1,730.3% +156.0% +71.3% +10.2% +3.1% -53.6%
– +10.4% +2,115.8% +193.8% +23.3% – – –
– – -94.2% -1,730.4% – -15.8% -249.8% –
– -45.9% -91.2% +15,780.6% -71.0% -10.7% -64.9% -52.6%
– -45.9% – -907.0% +4,682.0% – +93.2% -4.3%
– – – +91,666.7% – – – –
– -100.0% – +6,633.3% +66.3% +55.7% -32.9% -93.2%
– +0.0% -210.0% -95.7% – -104.2% +113.1% +64.9%
– +1,535,600.0% +2,914.1% -99.5% +298.9% +501.3% -48.0% -98.8%
– – +56,218.1% -116.6% – – – –
– – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?